Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp21 | Adrenal 3 | ECE2017

Is diabetes mellitus associated with catecholamine-secreting tumours always a secondary diabetes?

Baetu Mara , Stefanescu Ana Maria , Jercalau Simona , Tomulescu Victor , Tinu Anna-Maria , Badiu Corin

Introduction: Hyperglycaemia occurs frequently in catecholamine-secreting tumours due to insulin suppression or induced insulin resistance. These changes can be reversible postoperatory (postOp).Objective: Our study aims to establish the impact of surgery in patients with catecholamine-secreting tumours upon glucose metabolism disorders, as well as the predictive factors for postOp diabetes-free patients.Methods: We retrospectively...

ea0037ep866 | Thyroid cancer | ECE2015

Serum Galectin-3 in papillary thyroid cancer: preliminary results

Caragheorgheopol Andra , Schipor Sorina , Manda Dana , Stefanescu Ana-Maria , Ioachim Dumitru , Badiu Corin

Background: There are only few reports regarding the role of serum galectin-3 (Gal-3) as an early biochemical marker in thyroid carcinoma.Aim: To evaluate the potential overexpression of Gal-3 in sera from patients with confirmed diagnosis of papillary thyroid carcinoma (PTC).Patients and methods: We retrospectively investigated serum Gal-3 in 40 patients referred to the surgical department for thyroidectomy. Sera were collected be...

ea0035p60 | Adrenal Medulla | ECE2014

Olygosimptomatic malignant pheochromocytoma treated with 131I-MIBG

Jercalau Simona , Gabur Alexandra , Hortopan Dan , Stefanescu Ana Maria , Dumitrascu Anda , Badiu Corin

Introduction: Pheochromocytomas are rarely malignant, defined by the presence of cathecholamine – producing metastases. Malignant pheochromocytoma responds poorly to chemotherapy and radiotherapy. 131I-MIBG therapy can be used to prolong survival, with minor side effects.Case: A 45-years old woman known with malignant pheochromocytoma, with a long medical history, first came to our clinic in July 2012. Her diagnosis was suspected in 1999 ...

ea0026p366 | Adrenal medulla | ECE2011

Impact of surgery upon lipid profile in a case series of pheochromocytoma

Badiu Corin , Jercalau Simona , Gavan Vadim , Dobrescu Ruxandra , Tomulescu Victor , Beuran Mircea , Stefanescu Ana Maria

In pheochromocytoma, intense lypolitic activity may lead to altered lipid profile, which can reverse after tumour removal.Aim: In this study, we evaluated before and at 3 months after surgery for a cathecholamine secreting tumour, a group of 19 patients diagnosed with pheochromocytoma (17) or paraganglioma (2).Patients and methods: 13 women and 6 men, aged 53.68±12.75 years (36–75), presented with a clinical picture of pa...

ea0022p376 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Biochemical diagnosis strategy in pheochromocytoma

Stefanescu Ana-Maria , Schipor Sorina , Paun Diana-Loreta , Dumitrache Constantin , Badiu Corin-Virgil

Objective: The best biochemical strategy to follow in pheochromocytoma clinical diagnosis.Patients and methods: We selected two groups of patients: 24 pheochromocytomas (further diagnosed by CT): 20 women and 4 men aged 20–68 years and a normotensive group: 100 subjects without endocrine disfunction: 83 women and 17 men aged 19–70 years. In both groups we tested five parameters: plasma normetanephrines/metanephrines (NMNp/MNp); urine normetanep...

ea0022p377 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Carcinoid syndrome: biochemical diagnosis

Schipor Sorina , Stefanescu Ana-Maria , Paun Diana-Loreta , Dumitrache Constantin , Badiu Corin-Virgil

Objective: To introduce the best biochemical strategy for carcinoid syndrome diagnosis.Patients and methods: We selected two groups of patients: one group of 75 patients suspected of carcinoid syndrome: 57 women aged between 19 and 78 years and 18 men aged 17–81 years and a 80 healthy subjects group without endocrine disfunction: 56 women aged between 27 and 78 years and 24 men aged 17–81 years. We established median values for all parameters i...

ea0022p403 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Pheochromocytoma: seconds from disaster

Jercalau Simona Verzea , Dobrescu Ruxandra , Stefanescu Ana Maria , Beuran Mircea , Badiu Corin

A 50–year-old female with a 2 year-history of hypertension and diabetes was admitted to a county hospital, where treatment with clonidine and beta-blockers was started, without success. Abdominal CT showed a large left adrenal tumour, and her initial blood pressure (BP) was over 300/170 mmHg, which dropped to 80/30 mmHg. She was transferred for evaluation of a possible pheochromocytoma (PHEO). At admission her BP was 260/160 mmHg, heart rate (HR) 120 bpm, with anxiety, di...

ea0037ep315 | Calcium and Vitamin D metabolism | ECE2015

The peripheral serotonin, the serum osteocalcin and CrossLaps: the assay in menopausal women

Carsote Mara , Capatina Cristina , Caragheorgheopol Andra , Peretianu Dan , Manda Dana , Baloescu Rene , Stefanescu Ana Maria , Paun Diana , Poiana Catalina

Introduction: 17th European Congress of Endocrinology 2015. The skeleton health is reflected by the turnover markers as serum CrossLaps (CL=bone resorption), and serum osteocalcin (OC=bone formation), and by the calcium metabolism parameters (as ionic blood calcium, and, probably, by the 24-h urinary calcium=24-h ca). The peripheral serotonin might have intra-normal levels in patients with osteoporosis but yet represents a part of the complex equation related to the bone homeo...

ea0035p529 | Endocrine tumours and neoplasia | ECE2014

A rare ovarian carcinoma

Oros Sabina Elena , Rosca Roxana Irina , Paun Diana Loreta , Dumitrascu Anda Simona , Vladoiu Susana Vilma , Caragheorgheopol Andra , Stefanescu Ana Maria , Voinea Silviu , Radu Madalina Gabriela , Terzea Dana Cristina

We present a rare association of ovarian carcinoid and virilization. A 65-year-old woman presented with a 9 years history of obesity, hypertension, dyslipidemia, stable angina, evaluated ambulatory for a postmenopausal virilization syndrome and flushes, with high testosterone and 17-hydroxyprogesterone (17OHP) levels without suppression during the 2×2 mg DXM test, normal gynecological evaluations with no tumor formation involving uterus, ovaries and adrenals at the pelvic...